Microba Life Sciences

About:

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Top Investors: Alium Capital, ilab Accelerator, Sonic Healthcare, Microgen Plc

Description:

Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services using technology for measuring the human gut microbiota. The company analyzes the microbiome to discover therapeutics, develop new diagnostic tools to understand disease through comprehensive measurement of the human gut microbiome. Microba Life Sciences was established in March 2017 by Philip Hugenholtz and Gene Tyson in Brisbane, Queensland.

Total Funding Amount:

$21.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brisbane, Queensland, Australia

Founded Date:

2017-03-01

Contact Email:

info(AT)microba.com.au

Founders:

Gene Tyson, Philip Hugenholtz

Number of Employees:

51-100

Last Funding Date:

2022-11-28

IPO Status:

Public

Industries: